aTyr Pharma Financial Statements
1,222 Followers
aTyr Pharma Financial Overview
aTyr Pharma's market cap is currently ―. The company's EPS TTM is $-1.811; its P/E ratio is -1.95; aTyr Pharma is scheduled to report earnings on November 17, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ ― | $ ― | $ ― | $ ― | $ ― |
| EBIT | $ -12.38M | $ -8.64M | $ -7.73M | $ -10.45M | $ -7.20M |
| EBITDA | $ -12.08M | $ -8.32M | $ -7.40M | $ -10.09M | $ -6.91M |
| Net Income Common Stockholders | $ -12.15M | $ -8.56M | $ -7.67M | $ -10.39M | $ -7.15M |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | $ 31.69M | $ 36.15M | $ 44.06M | $ 50.64M | $ 98.67M |
| Total Assets | $ 104.78M | $ 115.54M | $ 123.92M | $ 48.99M | $ 55.13M |
| Total Debt | $ 994.00K | $ 1.29M | $ 1.58M | $ 1.85M | $ 2.13M |
| Net Debt | $ -30.70M | $ -34.86M | $ -42.48M | $ -48.78M | $ -96.54M |
| Total Liabilities | $ 6.40M | $ 6.41M | $ 6.48M | $ 8.19M | $ 5.60M |
| Stockholders Equity | $ 31.65M | $ 32.16M | $ 40.98M | $ 49.70M | $ 98.55M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.16M | $ -8.10M | $ -11.53M | $ -7.79M | $ -5.84M |
| Operating Cash Flow | $ -10.12M | $ -8.09M | $ -11.47M | $ -7.69M | $ -5.83M |
| Investing Cash Flow | $ 14.63M | $ -49.35M | $ -14.85M | $ -3.97M | $ -23.39M |
| Financing Cash Flow | $ 1.48M | $ 28.00K | $ 83.87M | $ 1.27M | $ 24.86M |
aTyr Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.